AANS Neurosurgeon | Volume 26, Number 1, 2017


Scientists Identify Novel Genes Linked to Motor Neuron Disease

Bookmark and Share

This study reveals three new risk genes for ALS, and one of these – C21orf2 – increases an individual’s risk of developing the disease by 65 percent. These results could aid the development of personalized treatments for people with ALS by using gene therapy – an approach which involves replacing faulty genes or adding new ones. One in every 400 people will be diagnosed with ALS at some point in their lives, yet its causes are largely unknown and effective treatments are therefore lacking. To read more, click here.


Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland

12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans

2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.

Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany

Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.

Interactive Calendar

Comments are closed.